RFP-Human Primary Mammary Adenocarcinoma Cells (MCF-7)

cAP-0108RFP

RFP-Human Primary Mammary Adenocarcinoma Cells (MCF-7)

1323.15 €

ALHC063-RFP

RFP-Human Primary Mammary Adenocarcinoma Cells (MCF-7)

400.3 €

cAP-0109RFP

RFP-Human Primary Mammary Ductal Carcinoma Cells (ZR-75-1)

1323.15 €

ABC-FC0032

RFP-Human Retinal Microvascular Pericytes

HRMPCs are initiated by elutriation from dissociated normal human retinal tissue and transfected with RFP-Lentiviral particles at passage 2. Zeocin resistant RPF-HRMPCs were selected and shipped in frozen vials (the cells are provided @ passage 4-5). Pericytes growth medium is recommended for cell culture and these cells have an average population doubling capacity 6 when cultured following the detailed protocol described below.

Ask for quotation

cAP-0108

Human Primary Mammary Adenocarcinoma Cells (MCF-7)

744 €

ABC-FC0047

HighQC™ RFP-Human Adipose Derived Mesenchymal Stem Cell

HAdMSCs are isolated from lipoaspirate derived from white adipose tissue and demonstrated with spindle-shaped-, and fibroblast-like cells. RFP-HAdMSCs are puromycin resistant HAdMSCs after trandsfected with lentiviruses expressing RFP under the control of CMV protomer. Each lot of RFP-HAdMSCs is tested to ensure the cells can be passaged at least three times (i.e., approximately 9 to 10 population doublings) after thaw in complete growth media (Mesenchymal Stem Cell Growth Medium (MSCGM)), when cultured following the detailed protocol described below.

Ask for quotation